Information  X 
Enter a valid email address

ABCAM Plc (ABC)

  Print      Mail a friend       Annual reports

Friday 23 November, 2007

ABCAM Plc

Shareholding

ABCAM Plc
23 November 2007


For immediate release                                        23 November 2007


                                    ABCAM PLC

                           ('Abcam' or 'the Company')



                                  Shareholding


Cambridge UK, 23 November 2007: Abcam plc announces that in accordance with the
FSA's Disclosure and Transparency Rules, the Company has been notified that, as
at 19 November 2007, Royal Bank of Scotland as Trustee of the Merrill Lynch UK
Smaller Companies Fund, had a direct interest in voting rights over 1,407,588
ordinary shares of 1p each in the Company amounting to approximately 4.0% of the
issued share capital of the Company.



For further information please contact:

Abcam                                                       + 44 (0) 1223 696000

Jonathan Milner, Chief Executive Officer
Jeff Iliffe, Chief Financial Officer
www.abcam.com

Numis Securities                                           + 44 (0) 20 7776 1500
James Black

Buchanan Communications                                    + 44 (0) 20 7466 5000
Mark Court / Mary-Jane Johnson



Notes for editors:


About Abcam plc

Abcam is a producer and distributor of research-grade antibodies headquartered
in Cambridge, UK, with a US office located in Cambridge, Massachusetts and a
Japanese office in Tokyo. Abcam was admitted to AIM in November 2005 and trades
under the ticker symbol ABC. The Company produces and distributes its own and
third party produced antibodies to academic and commercial users throughout the
world with product information provided and ordering available through the
Company's website, www.abcam.com. The antibodies are sold under the Abcam brand
name. The Company's vision is to build the largest online antibody resource in
the world while also ensuring that the antibodies are of high quality and
commercially viable. Abcam now has an online catalogue of approximately 40,000
products, most of which are antibodies, from over 200 suppliers supported by
up-to-date and detailed technical data sheets, which are created by the Company.
The Company currently employs 140 staff in its three operating companies.






                      This information is provided by RNS
            The company news service from the London Stock Exchange